You are here
Flumazenil Injection Cleared by FDA
Flumazenil Injection is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose.
Romazicon(R) Injection is a registered trademark of Roche Laboratories.
Source: American Pharmaceutical Partners, Inc.